Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study

Overview of attention for article published in Cancer Management and Research, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis

Article in Journal of Hematology (October 2023)

Application of pegaspargase in adult acute lymphoblastic leukemia and extranodal NK/T-cell lymphoma: a Chinese expert consensus (2022 version)

Article in Journal of Leukemia and Lymphoma (March 2023)

Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study

Article in British Journal of Haematology (February 2023)